Oxford Nanopore Technologies Ltd is a private company headquartered in Oxford, UK. The Company has raised £180m to date in the following fundraising rounds, and is currently well funded for the next phase of corporate development. The Company does not have traditional Venture Capital investment, instead the investor profile more closely mirrors that seen of publicly listed companies.
Seed funding was obtained in two rounds, from IP Group in 2005. In June 2006 the company raised £7.75m, and in March 2008 the company raised a further £10m.
In January 2009 the Company announced an $18m (£11.9m) investment from Illumina and a separate commercialisation agreement with Illumina for the Company's exonuclease sequencing technology. In this round the Company also raised an additional £2.1m in private investment from other sources.
In February 2010 Oxford Nanopore raised £17.4m from existing investors and new, undisclosed US-based investors.
In April 2011 the Company raised £25m from existing and new institutional and independent investors based in the UK and US.
In May 2012 the Company raised £34.1m ($50.8m), the majority of which was from existing investors.
In October 2013 Oxford Nanopore raised £40m from new and existing investors in the US and Europe.
In November 2013 Oxford Nanopore performed a secondary placing and divested Illumina's stake in the Company.
In August 2014 Oxford Nanopore raised £35m from new and existing investors in the US and Europe.
At this stage, Oxford Nanopore is not seeking additional investment. However, if you are interested in receiving information at the next opportunity then please use our contact form.